Related Experiment Videos
Topological investigation of amyloid fibrils obtained from beta2-microglobulin
Maria Monti1, Serena Principe, Sofia Giorgetti
1Dipartimento di Chimica Organica e Biochimica, Università di Napoli Federico II, via Cinthia 6, Italy.
Abstract:
Amyloid fibrils of patients treated with regular hemodialysis essentially consists of beta2-microglobulin (beta2-m) and its truncated species DeltaN6beta2-m lacking six residues at the amino terminus. The truncated fragment has a more flexible three-dimensional structure and constitutes an excellent candidate for the analysis of a protein in the amyloidogenic conformation. The surface topology of synthetic fibrils obtained from intact beta2-m and truncated DeltaN6beta2-m was investigated by the limited proteolysis/mass spectrometry approach that appeared particularly suited to gain insights into the structure of beta2-m within the fibrillar polymer. The distribution of prefential proteolytic sites observed in both fibrils revealed that the central region of the protein, which had been easily cleaved in the full-length globular beta2-m, was fully protected in the fibrillar form. In addition, the amino- and carboxy-terminal regions of beta2-m became exposed to the solvent in the fibrils, whereas they were masked completely in the native protein. These data indicate that beta2-m molecules in the fibrils consist of an unaccessible core comprising residues 20-87 with the strands I and VIII being not constrained in the fibrillar polymer and exposed to the proteases. Moreover, proteolytic cleavages observed in vitro at Lys 6 and Lys 19 reproduce specific cleavages that have to occur in vivo to generate the truncated forms of beta2-m occurring in natural fibrils. On the basis of these data, a possible mechanism for fibril formation from native beta2-m is discussed and an explanation for the occurrence of truncated protein species in natural fibrils is given.
Insights
Beta2-microglobulin (beta2-m) amyloid fibrils found in hemodialysis patients reveal a protected core and exposed termini in the fibrillar structure. This structural insight explains the presence of truncated beta2-m in natural amyloid deposits.
Area of Science:
- Biochemistry
- Structural Biology
- Medical Science
Background:
- Amyloid fibrils in hemodialysis patients primarily comprise beta2-microglobulin (beta2-m) and its truncated form, DeltaN6beta2-m.
- The truncated fragment offers a more flexible structure, making it suitable for studying amyloidogenic protein conformations.
Purpose of the Study:
- To investigate the surface topology of synthetic beta2-m fibrils using limited proteolysis and mass spectrometry.
- To understand the structural changes of beta2-m within the fibrillar polymer and explain the occurrence of truncated forms.
Main Methods:
- Limited proteolysis coupled with mass spectrometry was employed to analyze synthetic fibrils.
- Comparison of proteolytic sites in intact and truncated beta2-m fibrils with native beta2-m.
Main Results:
- The central region (residues 20-87) of beta2-m is protected within the fibril, unlike in the native protein.
- Amino- and carboxy-terminal regions of beta2-m are exposed in fibrils, contrasting with their masked state in native beta2-m.
- In vitro cleavage sites (Lys 6, Lys 19) correlate with in vivo generation of truncated beta2-m species.
Conclusions:
- Beta2-microglobulin molecules in fibrils feature an inaccessible core and exposed terminal regions.
- The study proposes a mechanism for beta2-m fibril formation and explains the presence of truncated variants in natural amyloid fibrils.